Loading chat...
IN HB1392
Bill
Status
1/17/2017
Primary Sponsor
David Frizzell
Click for details
AI Summary
-
Prohibits the Indiana Medicaid office, managed care organizations, and the Healthy Indiana Plan from requiring prior authorization for single source or brand name antiepilepsy and anticonvulsant drugs.
-
Requires unrestricted access to antiepilepsy and anticonvulsant drugs for program recipients, including a prohibition on requiring recipients to try unsuccessful drugs before receiving coverage for these medications.
-
Excludes antiepilepsy and anticonvulsant drugs from quantity limits and refill frequency restrictions that may otherwise apply to covered drugs.
-
Applies the same unrestricted access requirements to both the traditional Medicaid program and the Healthy Indiana Plan.
-
Effective July 1, 2017.
Legislative Description
Access to epilepsy medications. Prohibits the office of Medicaid policy and planning, a managed care organization, and the healthy Indiana plan from requiring in specified programs prior authorization for antiepilepsy and anticonvulsant drugs, and requires unrestricted access for recipients to these drugs.
Last Action
Representative Clere added as coauthor
2/9/2017